InMode Ltd.
| General Information | |
| Business: |
We are a leading global provider of innovative, energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s health. We have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. |
| Industry: | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees: | 209 |
| Founded: | 2008 |
| Contact Information | |
| Address | Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel |
| Phone Number | +972-4-9096313 |
| Web Address | http://www.inmodemd.com |
| View Prospectus: | InMode Ltd. |
| Financial Information | |
| Market Cap | $447.6mil |
| Revenues | $109.8 mil (last 12 months) |
| Net Income | $26.1 mil (last 12 months) |
| IPO Profile | |
| Symbol | INMD |
| Exchange | NASDAQ |
| Shares (millions): | 5.0 |
| Price range | $14.00 - $14.00 |
| Est. $ Volume | $70.0 mil |
| Manager / Joint Managers | Barclays/ UBS Investment Bank/ Canaccord Genuity |
| CO-Managers | Baird |
| Expected To Trade: | 8/8/2019 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |